DailyMed label
Alogliptin and Pioglitazone
DailyMed label · Padagis Israel Pharmaceuticals Ltd · version 11
Key facts
| Product | Alogliptin and Pioglitazone |
|---|---|
| Labeler | Padagis Israel Pharmaceuticals Ltd |
| Document type | HUMAN PRESCRIPTION DRUG LABEL |
| Active ingredients | Alogliptin Benzoate, Pioglitazone hydrochloride |
| Active ingredient UNIIs | EEN99869SC, JQT35NPK6C |
| Application number | NDA022426 |
| Route | ORAL |
| NDC package codes | 45802-260-65, 45802-351-65, 45802-499-65, 45802-402-65 |
| Effective date | Jul 28, 2025 |
| Set ID | 642b1e90-701e-42f2-bac6-a4918738e2c9 |
At a glance
- 1–9 NDC package codes
- 1–9 Active ingredients
- None Manufacturing establishments listed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About DailyMed drug labels
DailyMed publishes the structured product labeling (SPL) that companies submit to the FDA, including package NDCs, ingredients and the establishments that make each product.
Source: U.S. National Library of Medicine (NLM), DailyMed · Source date: